New Elite Feature: Screen & Chart at the same time

Caribou Biosciences, Inc.

Contributing Author

Recent Articles by Caribou Biosciences, Inc.

May-13	Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference CRBU GlobeNewswire
May-12	Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting CRBU GlobeNewswire
May-07	Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update CRBU GlobeNewswire
May-05	Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference CRBU GlobeNewswire
Mar-31	Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy CRBU +10.47% GlobeNewswire
Mar-05	Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update CRBU +6.43% CRBU GlobeNewswire
Feb-12	Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU GlobeNewswire
Feb-04	Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT and CIBMTR CRBU GlobeNewswire
Dec-01	Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 CRBU -8.76% GlobeNewswire
Nov-12	Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update CRBU -12.17% CRBU GlobeNewswire
Nov-03	Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU -10.70% CRBU GlobeNewswire
Nov-03	Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma CRBU GlobeNewswire
Nov-03	Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies CRBU GlobeNewswire
Nov-02	Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma CRBU GlobeNewswire
Aug-25	Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference CRBU +6.38% CRBU GlobeNewswire
Aug-12	Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update CRBU +8.94% CRBU GlobeNewswire
May-28	Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference CRBU GlobeNewswire
May-08	Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update CRBU GlobeNewswire
May-06	Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference CRBU -12.16% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)